These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 578067

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Symposium on the blood coagulation and fibrinolysis. (1) Pathophysiology of disseminated intravascular coagulation syndrome (author's transl)].
    Sakuragawa N.
    Nihon Naika Gakkai Zasshi; 1975 Oct 10; 64(10):3-7. PubMed ID: 1238483
    [No Abstract] [Full Text] [Related]

  • 27. Heparin neutralizing activity (HNA) and antithrombin III in coronary artery disease.
    Cella G, Russo R.
    Thromb Haemost; 1977 Oct 31; 38(3):696-700. PubMed ID: 579515
    [Abstract] [Full Text] [Related]

  • 28. Normal antithrombin-III activity and concentration in experimental disseminated intravascular coagulation.
    Müller-Berghaus G, Niepoth M, Rabens-Alles B, Rump E, Murano G.
    Scand J Clin Lab Invest Suppl; 1985 Oct 31; 178():107-13. PubMed ID: 3867111
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Correlation between acidosis and consumptional coagulopathy in foetal blood (author's transl)].
    Niedner W, König EM, Hofmann KD.
    Zentralbl Gynakol; 1981 Oct 31; 103(8):447-55. PubMed ID: 7269881
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [The treatment of disseminated intravascular coagulation in 18 cases of promyelocytic acute leukaemia (author's transl)].
    Dreyfus B, Varet B, Heilmann-Gouault M, Sultan C, Reyes F, Gluckman E, Basch A, Beaujean F.
    Nouv Rev Fr Hematol; 1973 Oct 31; 13(6):761-70. PubMed ID: 4280042
    [No Abstract] [Full Text] [Related]

  • 34. [Disseminated intravascular coagulation: antithrombin III and heparin].
    Thaler E.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977 Oct 31; 104(6):740-50. PubMed ID: 75143
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Hypercoagulability and stroke (author's transl)].
    Matsuda T.
    No To Shinkei; 1978 Jan 31; 30(1):13-25. PubMed ID: 346028
    [No Abstract] [Full Text] [Related]

  • 38. Plasma heparin neutralizing activity. Its use in the evaluation of thrombocytopenia and thrombocytosis.
    Dana B, Carvalho AC, Ellman L.
    Am J Clin Pathol; 1976 Jun 31; 65(6):964-9. PubMed ID: 945687
    [Abstract] [Full Text] [Related]

  • 39. Activated factor IX-antithrombin III complexes in human blood: quantification by an enzyme-linked differential antibody immunoassay and determination of the in vivo half-life.
    Takahashi I, Kato K, Sugiura I, Takamatsu J, Kamiya T, Saito H.
    J Lab Clin Med; 1991 Oct 31; 118(4):317-25. PubMed ID: 1940573
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.